Prognosis of cholangiocarcinoma patients based on multiple patterns of programmed cell death, integrated analysis of the immune microenvironment and drug sensitivity
PCD-associated Risk Score is a robust prognostic tool for CHOL, influencing TME modulation and therapeutic response, and may guide personalized treatment strategies.
Authors
- Yi‐Ming Chen (ORCID: https://orcid.org/0000-0001-7593-3065)
- Xin Yan (ORCID: https://orcid.org/0000-0003-1147-8555)
- Jian Sun (ORCID: https://orcid.org/0000-0001-8483-7198)
- Yupeng Xu (ORCID: https://orcid.org/0000-0002-4788-7003)
- Zhengfa Mao
Institutions
- Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2025-05-14
- DOI
- https://doi.org/10.3389/fgene.2025.1457204
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00